Bosch John Roderick Ten Sells 1,417 Shares of Billiontoone (NASDAQ:BLLN) Stock

Billiontoone, Inc. (NASDAQ:BLLN) SVP Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $100.00, for a total value of $141,700.00. Following the sale, the senior vice president owned 26,467 shares in the company, valued at $2,646,700. The trade was a 5.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bosch John Roderick Ten also recently made the following trade(s):

• On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The shares were sold at an average price of $92.86, for a total transaction of $131,582.62.
• On Monday, June 29th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $120.00, for a total transaction of $169,920.00.
• On Monday, June 15th, Bosch John Roderick Ten sold 2,832 shares of Billiontoone stock. The stock was sold at an average price of $101.47, for a total transaction of $287,363.04.

Billiontoone Stock Performance

BLLN stock traded down $1.07 during mid-day trading on Thursday, hitting $95.15. The company had a trading volume of 670,193 shares, compared to its average volume of 841,632. The company has a debt-to-equity ratio of 0.17, a quick ratio of 11.31 and a current ratio of 11.69. The firm has a market cap of $4.49 billion and a PE ratio of 137.46. Billiontoone, Inc. has a 12 month low of $61.96 and a 12 month high of $150.44. The stock’s fifty day moving average price is $115.34 and its two-hundred day moving average price is $95.29.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The company had revenue of $109.45 million during the quarter. On average, analysts forecast that Billiontoone, Inc. will post 0.83 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Wall Street Zen downgraded shares of Billiontoone from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. JPMorgan Chase & Co. lowered their price target on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a research report on Thursday, August 6th. BTIG Research dropped their price target on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research note on Thursday, August 6th. Weiss Ratings upgraded shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, June 23rd. Finally, Guggenheim began coverage on shares of Billiontoone in a report on Monday, June 29th. They set a “buy” rating and a $125.00 target price on the stock. Six equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $126.71.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Adams Street Partners LLC bought a new stake in Billiontoone during the 4th quarter worth approximately $140,063,000. Price T Rowe Associates Inc. MD bought a new position in Billiontoone in the 4th quarter valued at $39,717,000. JPMorgan Chase & Co. bought a new position in Billiontoone in the 4th quarter valued at $32,078,000. Wasatch Advisors LP purchased a new position in shares of Billiontoone during the 1st quarter valued at $29,179,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of Billiontoone in the fourth quarter worth $18,631,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.